{"id":"W4406971619","doi":"10.1200/go-24-00464","title":"Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources","year":2025,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University","funders":"Genentech; Exelixis; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Docetaxel; Prostate cancer; Cyclophosphamide; Regimen; Prostate-specific antigen; Oncology; Internal medicine; Cancer; Prostate; Urology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001310539,0.0001413653,0.0005273233,0.00011975,0.00006453124,0.000008283086,0.00006920927,0.00006178596,0.00001337533],"category_scores_gemma":[0.00005539843,0.0000983174,0.00005130377,0.0005681604,0.0001361348,0.00004029247,0.00002890602,0.0001064129,7.105261e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002009761,"about_ca_system_score_gemma":0.002838928,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003621165,"about_ca_topic_score_gemma":0.01870638,"domain_scores_codex":[0.9986798,0.00008424919,0.000377791,0.0002712285,0.0002051372,0.0003818593],"domain_scores_gemma":[0.9991403,0.00007912986,0.0001540055,0.0001459997,0.00037715,0.0001033828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02907695,0.001220698,0.8998955,0.00132158,0.0004079112,0.00007460967,0.002793306,0.0001374133,0.00006929172,0.0003776066,0.002109267,0.06251587],"study_design_scores_gemma":[0.02582881,0.009674984,0.9319665,0.0006631848,0.0002001687,0.000002328558,0.002064107,0.00005829096,0.0002012125,0.0001659063,0.0290354,0.0001391434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986748,0.004732497,0.00001072574,0.004215987,0.0001226623,0.002578954,0.0006224141,0.00001817492,0.0009506242],"genre_scores_gemma":[0.9965301,0.0002188529,0.001706055,0.0005247784,0.00001314073,0.000386047,0.0002077527,0.000009576341,0.0004037421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06237673,"threshold_uncertainty_score":0.9991997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01873738713748683,"score_gpt":0.3784184127034239,"score_spread":0.3596810255659371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}